BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaumaya PT, Foy KC. Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy. Future Oncol. 2012;8:961-987. [PMID: 22894670 DOI: 10.2217/fon.12.95] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 He X, Abrams SI, Lovell JF. Peptide Delivery Systems for Cancer Vaccines. Adv Therap 2018;1:1800060. [DOI: 10.1002/adtp.201800060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
2 Nagamani S, Gaur AS, Tanneeru K, Muneeswaran G, Madugula SS, Consortium M, Druzhilovskiy D, Poroikov VV, Sastry GN. Molecular property diagnostic suite (MPDS): Development of disease-specific open source web portals for drug discovery. SAR and QSAR in Environmental Research 2017;28:913-26. [DOI: 10.1080/1062936x.2017.1402819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
3 Gokhale AS, Sable R, Walker JD, McLaughlin L, Kousoulas KG, Jois SD. Inhibition of cell adhesion and immune responses in the mouse model of collagen-induced arthritis with a peptidomimetic that blocks CD2-CD58 interface interactions. Biopolymers 2015;104:733-42. [PMID: 26031942 DOI: 10.1002/bip.22692] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bou-Dargham MJ, Draughon S, Cantrell V, Khamis ZI, Sang QA. Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy. J Cancer 2021;12:6949-63. [PMID: 34729098 DOI: 10.7150/jca.64205] [Reference Citation Analysis]
5 Zhang L, He D, Huang J, Deng Y, Weng R, Pan L, Deng N. The Immunogenicity and Immunoprotection of VBP3 Multi-epitope Vaccine Targeting Angiogenesis and Tumor Inhibition in Lung Cancer-Bearing Mice. Int J Pept Res Ther 2019;25:215-25. [DOI: 10.1007/s10989-017-9667-4] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Sánchez F, Sáez M, Lunello P, Ponz F. Plant viral elongated nanoparticles modified for log-increases of foreign peptide immunogenicity and specific antibody detection. J Biotechnol 2013;168:409-15. [PMID: 24055625 DOI: 10.1016/j.jbiotec.2013.09.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
7 Guyot M, Hilmi C, Ambrosetti D, Merlano M, Lo Nigro C, Durivault J, Grépin R, Pagès G. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies. Oncotarget 2017;8:9174-88. [PMID: 27999187 DOI: 10.18632/oncotarget.13942] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
8 Han G, Wang Y, Bi W, Jia J, Wang W, Xu M. Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma. Clin Exp Med 2016;16:577-84. [PMID: 26319790 DOI: 10.1007/s10238-015-0382-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
9 Chen Q, Zhou Z, Shan L, Hua Y, Zeng H, Liu P, Cai Z. Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update. Biomed Rep 2014;2:823-30. [PMID: 25279153 DOI: 10.3892/br.2014.317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
10 Kaumaya PT. B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine. Future Oncol 2020;16:1767-91. [PMID: 32564612 DOI: 10.2217/fon-2020-0224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Calvanese L, Caporale A, Focà G, Iaccarino E, Sandomenico A, Doti N, Apicella I, Incisivo GM, De Falco S, Falcigno L, D’auria G, Ruvo M. Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications. Amino Acids 2018;50:321-9. [DOI: 10.1007/s00726-017-2519-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lancaster EM, Jablons D, Kratz JR. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development. Genetic Testing and Molecular Biomarkers 2020;24:59-66. [DOI: 10.1089/gtmb.2018.0211] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Zhang H, Jia E, Xia W, Lv T, Lu C, Xu Z, Zhu W. Utilizing VEGF165b mutant as an effective immunization adjunct to augment antitumor immune response. Vaccine 2019;37:2090-8. [DOI: 10.1016/j.vaccine.2019.02.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Masoud V, Pagès G. Targeted therapies in breast cancer: New challenges to fight against resistance. World J Clin Oncol 2017; 8(2): 120-134 [PMID: 28439493 DOI: 10.5306/wjco.v8.i2.120] [Cited by in CrossRef: 140] [Cited by in F6Publishing: 114] [Article Influence: 28.0] [Reference Citation Analysis]
15 Kaumaya PT. A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy. Hum Vaccin Immunother 2015;11:1368-86. [PMID: 25874884 DOI: 10.1080/21645515.2015.1026495] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
16 Fry EA, Taneja P, Inoue K. Clinical applications of mouse models for breast cancer engaging HER2/neu. Integr Cancer Sci Ther 2016;3:593-603. [PMID: 28133539 DOI: 10.15761/ICST.1000210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zhang Q, Lao X, Huang J, Zhu Z, Pang L, Tang Y, Song Q, Huang J, Deng J, Deng N, Yang Q, Sengupta AM, Xiong L. Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide. Biotechnol Prog 2015;31:194-203. [PMID: 25271020 DOI: 10.1002/btpr.1997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
18 Gokhale A, Kanthala S, Latendresse J, Taneja V, Satyanarayanajois S. Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in mice. Chem Biol Drug Des 2013;82:106-18. [PMID: 23530775 DOI: 10.1111/cbdd.12138] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
19 Doti N, Mardirossian M, Sandomenico A, Ruvo M, Caporale A. Recent Applications of Retro-Inverso Peptides. Int J Mol Sci 2021;22:8677. [PMID: 34445382 DOI: 10.3390/ijms22168677] [Reference Citation Analysis]
20 Reyes HD, Thiel KW, Carlson MJ, Meng X, Yang S, Stephan JM, Leslie KK. Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers. Mol Diagn Ther 2014;18:137-51. [PMID: 24403167 DOI: 10.1007/s40291-013-0070-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
21 Gehrmann M, Stangl S, Foulds GA, Oellinger R, Breuninger S, Rad R, Pockley AG, Multhoff G. Tumor imaging and targeting potential of an Hsp70-derived 14-mer peptide. PLoS One 2014;9:e105344. [PMID: 25165986 DOI: 10.1371/journal.pone.0105344] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
22 Li Y, Xiao J, Zhang Q, Yu W, Liu M, Guo Y, He J, Liu Y. The association between anti-tumor potency and structure-activity of protein-kinases inhibitors based on quinazoline molecular skeleton. Bioorganic & Medicinal Chemistry 2019;27:568-77. [DOI: 10.1016/j.bmc.2018.12.032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
23 Foy KC, Wygle RM, Miller MJ, Overholser JP, Bekaii-Saab T, Kaumaya PT. Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivo. J Immunol. 2013;191:217-227. [PMID: 23698748 DOI: 10.4049/jimmunol.1300231] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
24 Gokhale AS, Satyanarayanajois S. Peptides and peptidomimetics as immunomodulators. Immunotherapy 2014;6:755-74. [PMID: 25186605 DOI: 10.2217/imt.14.37] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
25 Kaumaya PT. Bridging oncology and immunology: expanding horizons with innovative peptide vaccines and peptidomimetics. Immunotherapy 2013;5:1159-63. [PMID: 24188668 DOI: 10.2217/imt.13.128] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
26 Chen D, Zhang YJ, Zhu KW, Wang WC. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma. Tumour Biol. 2013;34:1895-1899. [PMID: 23589053 DOI: 10.1007/s13277-013-0733-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
27 Li Z, Ding J, Zhao X, Qi G. Combination therapy of hepatocellular carcinoma by DNA shuffling-based VEGF vaccine and doxorubicin. Immunotherapy 2018;10:951-69. [PMID: 30114953 DOI: 10.2217/imt-2017-0194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Sun J, Li X, Chen P, Gao Y. From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer. J Inflamm Res 2022;15:4061-85. [PMID: 35873388 DOI: 10.2147/JIR.S368138] [Reference Citation Analysis]
29 Liu F, Luo L, Wei Y, Wang W, Wen T, Yang J, Xu M, Li B. Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population. Oncotarget 2017;8:16488-97. [PMID: 28147320 DOI: 10.18632/oncotarget.14870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
30 Ramadan HK, Meghezel EM, Abdel-Malek MO, Askar AA, Hetta HF, Mahmoud AA, Abdel-Aal AM. Correlation Between Vascular Endothelial Growth Factor and Long-Term Occurrence of HCV-Related Hepatocellular Carcinoma After Treatment with Direct-Acting Antivirals. Cancer Invest 2021;39:653-60. [PMID: 34224250 DOI: 10.1080/07357907.2021.1951751] [Reference Citation Analysis]
31 Foy KC, Miller MJ, Overholser J, Donnelly SM, Nahta R, Kaumaya PT. IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides. Oncoimmunology 2014;3:e956005. [PMID: 25941587 DOI: 10.4161/21624011.2014.956005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
32 Jin D, Yu X, Chen B, Li Z, Ding J, Zhao X, Qi G. Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model. Immunotherapy 2017;9:537-53. [PMID: 28509606 DOI: 10.2217/imt-2017-0004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]